RapidArc dynamic versus RapidArc: A multi anatomical‐site dosimetric evaluation
Journal of Applied Clinical Medical Physics · 2026-01 · 27 (1)
DOI: 10.1002/acm2.70404 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Applied Clinical Medical Physics, online erschienen am 14.01.2026. Verfasst von Aram Rostami und 13 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Department, National Center for Cancer Care and Research, Doha, Qatar. Hauptthemen laut MEDLINE: Radiotherapy Planning, Computer-Assisted, Radiotherapy, Intensity-Modulated, Organs at Risk, Prostatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
RapidArc (RA) has advanced VMAT delivery; however, challenges remain in achieving optimal organ‐at‐risk (OAR) sparing in complex cases. RapidArc Dynamic (RAD), a next‐generation Volumetric Modulation Arc Therapy (VMAT) technique, incorporates dynamic collimator rotation, embedded static fields, and a faster optimizer to enhance dose modulation. This study compares dosimetric outcomes between conventional RA and RAD across four anatomical sites.
Methods
A retrospective analysis was conducted on 40 patients (10 each for breast, lung SBRT, prostate, and head and neck cancers). Each case was initially treated with RA and subsequently replanned using RAD in Eclipse v18.1. Plans were evaluated using dose–volume histograms (DVH), and paired t‐tests assessed differences in target coverage and OAR sparing ( p < 0.05).
Results
RAD maintained equivalent target coverage compared to RA across all sites. Significant OAR sparing was observed with RAD, including reduced mean heart and contralateral lung doses in breast cases, lower rectal and bladder doses in prostate cases, improved conformity and reduced spinal cord and lung doses in lung SBRT, and superior sparing of parotids, cochleae, and mucosal structures in head and neck cases.
Conclusion
RAD offers superior OAR sparing and improved dose conformity without compromising target coverage compared to conventional RA. These results support RAD's clinical adoption, particularly for anatomically complex or high‐precision treatments. Further prospective studies are needed to assess the long‐term clinical benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Radiation Oncology Department, National Center for Cancer Care and Research, Doha, Qatar.
- Nuclear Science & Technology Research Institute, Tehran, Iran.
ORCID-Profile: Mojtaba Barzegar
Zitieren
APA
Rostami, A., Naim, C., Sukumaran, R. P., Usman, M., Mkanna, A. Y., Al-Sabahi, A. F., Basith, A., Chuck, S., Barzegar, M., Peltier, B. O., Aklan, B., Baradaran, S., Paloor, S. P., & Hammoud, R. W. (2026). RapidArc dynamic versus RapidArc: A multi anatomical‐site dosimetric evaluation. Journal of Applied Clinical Medical Physics, 27(1). https://doi.org/10.1002/acm2.70404
Vancouver
Rostami A, Naim C, Sukumaran RP, Usman M, Mkanna AY, Al-Sabahi AF, et al. RapidArc dynamic versus RapidArc: A multi anatomical‐site dosimetric evaluation. Journal of Applied Clinical Medical Physics. 2026;27(1). doi:10.1002/acm2.70404
BibTeX
@article{Rostami2026,
author = {Rostami, Aram and Naim, Carole and Sukumaran, Renilmon Pottanplackal and Usman, Mohammad and Mkanna, Abbass Yousef and Al-Sabahi, Alla Fuad and Basith, Ahamed and Chuck, Shelton and Barzegar, Mojtaba and Peltier, Bevan Orville and Aklan, Bassim and Baradaran, Samaneh and Paloor, Satheesh Prasad and Hammoud, Rabih Wafiq},
title = {RapidArc dynamic versus RapidArc: A multi anatomical‐site dosimetric evaluation},
journal = {Journal of Applied Clinical Medical Physics},
year = {2026},
volume = {27},
number = {1},
doi = {10.1002/acm2.70404}
}
EUVIMED